While its announcement of a new low-cost sequencing platform caused one blogger to lose some sleep, Illumina has Forbes' Matthew Herper contemplating the consequences of the Life Technologies Ion Personal Genome Machine's new competition within the sequencing market.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have an account?
Login Now.